OcuNexus' Scientific Co-Founders

David Becker. Ph.D

Professor David Becker obtained his BSC in 1985 and PhD in 1988. He was awarded a prestigious 10 year Royal Society Research Fellowship in 1994 and is now a Reader in Cellular Imaging at University College London which is ranked in the top 10 research Universities in the world. Prof. Becker has published over 80 research articles and book chapters, with a Publication H-Index of 24 and acts as a reviewer for over 35 international journals and over 16 national and international grant funding agencies (including the USA NSF and NIH, New Zealand, Israel, the UK Wellcome Trust, MRC, BBSRC and The Royal Society). He is Director of the Centre for Cell and Molecular Dynamics imaging facility for the Faculty of Life Sciences UCL, which he has built up to be one of the best live cell imaging facilities worldwide, housing 10 confocal and multiphoton microscopes. In 2003 Prof. Becker won the Medical Futures Nomura award for the Best Biotech Start-Up Innovation.

Colin Green. Ph.D

Professor Green holds the W&B Hadden Chair of Ophthalmology and Translational Vision Research at the University of Auckland, New Zealand. He is Deputy Head of Department of Ophthalmology and on the Research Committee of the New Zealand National Eye Centre. He has 40 years of research experience including 12 years in France, United States (Baylor College of Medicine) and England (as a Royal Society Research Fellow and Reader, University College London). He has published >165 research manuscripts (including one in Science and two in Nature) and has an H index = 43. He is regularly asked to speak internationally and has served on several grant review panels within New Zealand as well as for international grant funding bodies. Dr Green has supervised 60 postgraduate students to completion with several winning awards for entrepreneurship. Dr Green’s own work has won the International Robert Feulgen Prize (1992), an Arthritis New Zealand Distinguished Service Award (2012), the Dame Ida Mann Lecture for Royal Australian and New Zealand College of Ophthalmologists (2012) and the University of Auckland Vice-Chancellor's Commercialisation Medal (2014). Dr Green was a founding scientist and director for CoDa Therapeutics (NZ) Ltd and CoDaTherapeutics Inc. USA. His team is world leading on the role of gap junction channels in injury and disease, with new treatments for ocular disease that go beyond the treatment of clinical signs to target underlying causes. His discoveries on connexin hemichannel roles in vascular dropout and perpetuation of the inflammasome pathway impact upon the understanding of many acute and chronic disease conditions. Dr Green is an inventor on over thirty patent families.